Yuanyuan Zhang

6PUBLICATIONS
19CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2024
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor.

Zhenfei Zhou, Siqi Huang, Shijie Fan

|Nov 22, 2023
PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma.

Hongru Tao, Chen Jin, Liyuan Zhou

|Jun 21, 2022
L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression.

Jing Huang, Xiaobo Wang, Bing Li

|May 06, 2022
Discovery of trisubstituted nicotinonitrile derivatives as novel human GCN5 inhibitors through AlphaScreen-based high throughput screening.

Hongru Tao, Jun Wang, Wenchao Lu

|Jun 02, 2021
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction.

Daohai Du, Dandan Xu, Licheng Zhu

|Nov 03, 2018
Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma.

Wei Chen, Hao Zhang, Zhifeng Chen

Pageof 1

Frequent Collaborators

4 joint publications

Cheng Luo

1 joint publications

Clemens Zwergel

1 joint publications

Naixia Zhang

1 joint publications

Sergio Valente